title: Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.
abstract: Inclusion body myositis (IBM) represents a serious debilitating disease of muscle without identifiable cause or treatment. Muscle biopsy specimens have characteristic rimmed vacuoles, varying degrees of inflammation, and, most importantly, cytoplasmic and intranuclear filamentous inclusions of unknown composition. Fresh-frozen sections of muscle biopsy specimens from 24 IBM cases were stained with Congo red dye (pH, 10.5 to 11.0). Control biopsy specimens included polymyositis, dermatomyositis, hereditary vacuolar myopathies of unknown cause, acid maltase deficiency, distal myopathy, oculopharyngeal dystrophy, and chloroquine myopathy. Sections were also immunostained with antibody to transthyretin, human P component, and immunoglobulin light chains. In the vacuolated fibers in IBM, amyloidogenic green-birefringent deposits were seen. Some deposits were delicate and wispy appearing, and others were plaque-like. The size of deposits varied, measuring 1 x 2 to 8 microns, and rarely up to 20 microns in length. The number of amyloid-positive fibers correlated with the number of vacuolated fibers. Similar deposits were seen in one case of distal myopathy and one hereditary vacuolar myopathy. Other control cases were negative for amyloid deposits. Antibody staining for known amyloidogenic proteins was negative. This study demonstrates that the filaments in IBM share properties with amyloid proteins. The location implies that this amyloid material is formed intracellularly, rather than having a systemic derivation. The association of amyloid deposits with autophagic vacuoles in IBM raises the likely possibility that the filaments represent a modification of a normal protein within an acidic degradative vacuolar compartment. An alternative possibility, considering the shared properties of IBM filaments and prions (which include size and amyloidogenic properties), is that IBM represents a human prion disease.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Neurology, College of Medicine, Ohio State University, Columbus 43210.
authors.forename: J R
authors.initials: JR
authors.lastname: Mendell
authors.forename: Z
authors.initials: Z
authors.lastname: Sahenk
authors.forename: T
authors.initials: T
authors.lastname: Gales
authors.forename: L
authors.initials: L
authors.lastname: Paul
mesh_terms: D000328:Adult; D000368:Aged; D000682:Amyloid / Q000032:analysis*; D005260:Female; D006801:Humans; D002479:Inclusion Bodies / Q000737:chemistry / Q000473:pathology*; D007382:Intermediate Filaments / Q000737:chemistry / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000378:metabolism / Q000473:pathology; D009220:Myositis / Q000378:metabolism / Q000473:pathology*; D014617:Vacuoles / Q000473:pathology
chemical_list: D000682:Amyloid